NR4A1 and breast carcinoma: This study demonstrates that early‐stage BRCA‐associated hormone receptor‐positive breast cancers have higher Oncotype DX Breast Recurrence Score® results, less progesterone receptor expression and higher nuclear grade compared to those without BRCA mutations, however, relapse‐free survival and overall survival were not significantly different when adjusting for Recurrence Score®.